By Professor Glenda Halliday

Journal articles

Mehta P; Mellick GD; Rowe DB; Halliday GM; Jones MM; Manwaring N; Vandebona H; Silbum P; Wang JJ; Mitchell P; Sue C, 2009, 'Mitochondrial DNA Haplogroups J and K are not Protective for Parkinson`s Disease in the Australian Community', Movement Disorders, 24, pp. 290 - 292

Sokolova A; Hill MD; Rahimi F; Warden LA; Halliday GM; Shepherd CE, 2009, 'Monocytle chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease', Brain Pathology, 19, pp. 392 - 398

Dickson D; Braak H; Duda J; Duyckaerts C; Gasser T; Halliday GM; Hardy J; Leverenz J; Del Tredici K; Wszolek Z; Litvan I, 2009, 'Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria', , 8, pp. 1150 - 1157

Halliday GM; Herrero M; Murphy K; Mccann H; Ros-Bernal F; Barcia C; Mori H; Blesa F; Obeso J, 2009, 'No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism', Movement Disorders, 24, pp. 1519 - 1545

Mackenzie IR; Neumann M; Bigio E; Cairns NJ; Alafuzoff I; Kril J; Kovacs G; Ghetti B; Halliday GM; Holm I; Ince PG; Kamphorst W; Revesz T; Rozemuller A; Kumar-Singh S; Akiyama H; Baborie A; Spina S; Dickson DW; Trojanowski JQ; Mann DM, 2009, 'Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: Consensus recommendations', ACTA Neuropathologica, 117, pp. 15 - 18

Shepherd CE; Gregory G; Warden L; Halliday G, 2009, 'O2‐03‐02: Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease', Alzheimer's & Dementia, 5, http://dx.doi.org/10.1016/j.jalz.2009.05.335

Monoranu C; Apfelbacher M; Grunblatt E; Puppe B; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Halliday GM; Kril J; Harper C; Mclean C; Riederer P; Roggendorf W, 2009, 'pH measurement as quality control on human post mortem brain tissue: A study of the BrainNet Europe consortium', Neuropathology and Applied Neurobiology, 35, pp. 329 - 337

Van Eersel J; Bi M; Ke Y; Hodges JR; Xuereb J; Gregory GC; Halliday GM; Gotz J; Kril J; Ittner L, 2009, 'Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains', Journal of Neural Transmission, 116, pp. 1243 - 1251

Truong L; Brooks D; Amaral F; Henderson J; Halliday GM, 2009, 'Relative preservation of thalamic centromedian nucleus in Parkinsonian patients with dystonia', Movement Disorders, 24, pp. 2128 - 2135

Halliday GM, 2009, 'Thalamic changes in Parkinson's disease', Parkinsonism and Related Disorders, 15S3, pp. S152 - S155

Davies R; Halliday GM; Xuereb J; Kril J; Hodges JR, 2009, 'The neural basis of semantic memory: Evidence from semantic dementia', Neurobiology of Aging, 30, pp. 2043 - 2052

Grunblatt E; Monoranu C; Apfelbacher M; Keller D; Michel T; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Mclean C; Halliday GM; Harper C; Deckert J; Roggendorf W; Riederer P, 2009, 'Tryptophan is a marker of human postmortem brain tissue quality', Journal of Neurochemistry, 110, pp. 1400 - 1408

Mevawalla N; Fung VS; Morris JC; Halliday GM, 2009, 'Unilateral rest tremor in vascular Parkinsonism associated with a contralateral lesion of the locus coeruleus', Movement Disorders, 24, pp. 1242 - 1244

Shepherd CE; Mccann H; Halliday GM, 2009, 'Variations in the neuropathology of familial Alzheimer's disease', ACTA Neuropathologica, 118, pp. 37 - 52

Piguet O; Double KL; Kril J; Harasty JA; Macdonald V; Mcritchie DA; Halliday GM, 2009, 'White matter loss in healthy ageing: A postmortem analysis', Neurobiology of Aging, 30, pp. 1288 - 1295

Hersey P; Halliday GM; Farrelly ML; DeSilva C; Lett M; Menzies SW, 2008, 'Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma', CANCER IMMUNOLOGY IMMUNOTHERAPY, 57, pp. 1039 - 1051, http://dx.doi.org/10.1007/s00262-007-0435-8

Halliday GM; Lyons JG, 2008, 'Inflammatory doses of UV may not be necessary for skin carcinogenesis', Photochemistry and Photobiology, 84, pp. 272 - 283, http://dx.doi.org/10.1111/j.1751-1097.2007.00247.x

Huang Y; Halliday GM; Mastaglia FL; Rowe DB; Sue CM, 2008, '410: Autosomal dominant late-onset Parkinson’s disease due to a novel A1442P mutation in the LRRK2 gene', Journal of Clinical Neuroscience, 15, pp. 344 - 345, http://dx.doi.org/10.1016/j.jocn.2007.07.023

Loy CT; Brooks BS; Taddei K; Patton A; McLean C; Halliday GM; Martins R; Kwok JB; Schofield PR, 2008, '417: A consanguineous family with Frontotemporal Dementia/Motor Neuron Disease', Journal of Clinical Neuroscience, 15, pp. 347 - 347, http://dx.doi.org/10.1016/j.jocn.2007.07.030

Halliday GM, 2008, 'Clarifying the pathological progression of Parkinson`s disease', ACTA Neuropathologica, 115, pp. 377 - 378, http://dx.doi.org/10.1007/s00401-008-0353-7

Murphy KE; Karaconji T; Hardman CD; Halliday GM, 2008, 'Excessive dopamine neuron loss in progressive supranuclear palsy', Movement Disorders, 23, pp. 607 - 610, http://dx.doi.org/10.1002/mds.21907

Sutherland GR; Mellick GD; Newman J; Double KL; Stevens J; Lee L; Rowe DB; Silburn PA; Halliday GM, 2008, 'Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson`s disease', American Journal of Medical Genetics Part B - Neuropsychiatric Genetics, 147B, pp. 495 - 499, http://dx.doi.org/10.1002/ajmg.b.30633

Halliday GM; Mccann H, 2008, 'Human-based studies on alpha-synuclein deposition and relationship to Parkinson`s disease symptoms', Experimental Neurology, 209, pp. 12 - 21, http://dx.doi.org/10.1016/j.expneurol.2007.07.006

Huang Y; Song YC; Murphy KE; Holton J; Lashley T; Revesz T; Gai WP; Halliday GM, 2008, 'LRRK2 and parkin immuoreactivity in multiple system atrophy inclusions', ACTA Neuropathologica, 116, pp. 639 - 646

Young VG; Halliday GM; Kril J, 2008, 'Neuropathologic correlates of white matter hyperintensities', Neurology, 71, pp. 804 - 811

Elliott DA; Kim WS; Halliday GM; Garner B, 2008, 'P3‐294: Post‐translational modifications of apolipoprotein‐e in the human brain', Alzheimer's & Dementia, 4, http://dx.doi.org/10.1016/j.jalz.2008.05.1862

Luty A; Kwok JB; Thompson E; Blumbergs PC; Brooks WS; Loy CT; Dobson-Stone C; Panegyres P; Hecker J; Nicholson GA; Halliday GM; Schofield PR, 2008, 'Pedigree with frontotemporal lobar degeneration - motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9', BMC NEUROLOGY, 8

Double KL; Dedov V; Fedorow HS; Kettle E; Halliday GM; Garner B; Brunk U, 2008, 'The comparative biology of neuromelanin and lipofuscin in the human brain', CMLS - Cellular and Molecular Life Sciences, 65, pp. 1669 - 1682, http://dx.doi.org/10.1007/s00018-008-7581-9

Halliday GM; Hely MA; Reid WG; Morris JG, 2008, 'The progression of pathology in longitudinally followed patients with Parkinson`s disease', ACTA Neuropathologica, 115, pp. 409 - 415, http://dx.doi.org/10.1007/s00401-008-0344-8

Hely MA; Reid WG; Adena MA; Halliday GM; Morris JG, 2008, 'The Sydney multicenter study of Parksinon`s disease: The inevitability of dementia at 20 years', Movement Disorders, 23, pp. 837 - 844

Karlstrom H; Brooks WS; Kwok JB; Broe T; Kril J; Mccann H; Halliday GM; Schofield PR, 2008, 'Variable phenotype of Alzheimer's disease with spastic paraparesis', Journal of Neurochemistry, 104, pp. 573 - 583, http://dx.doi.org/10.1111/j.1471-4159.2007.05038.x

Christine Song YJ; Huang Y; Lundvig D; Gai WP; Blumbergs P; Hojrup P; Otzen D; Halliday G; Jensen P, 2007, '1.210 P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy', Parkinsonism & Related Disorders, 13, pp. S63 - S63, http://dx.doi.org/10.1016/s1353-8020(08)70483-8

Stevens J; Huang Y; Vandenbona H; Halliday GM; Mellick G; Mastaglia F; Kwok J; Sue CM, 2007, '307: Prevalence of LRRK2 mutations in Australians with Parkinson’s Disease', Journal of Clinical Neuroscience, 14, pp. 1009 - 1010, http://dx.doi.org/10.1016/j.jocn.2007.02.013

Piguet O; Bennett HP; Waite LM; Kril JJ; Creasey H; Broe GA; Halliday GM, 2007, '619: Preserved cognition and functional independence after a large right PCA infarct: longitudinal clinical and neuropathological findings', Journal of Clinical Neuroscience, 14, pp. 1023 - 1024, http://dx.doi.org/10.1016/j.jocn.2007.02.050

Schofield EC; McCredie RL; Halliday GM; Cordato NJ, 2007, '621: Changes in regional cerebral blood flow relate to cognitive and behavioural symptoms in progressive supranuclear palsy', Journal of Clinical Neuroscience, 14, pp. 1024 - 1025, http://dx.doi.org/10.1016/j.jocn.2007.02.052

Brooks DJ; Harding AJ; Halliday GM, 2007, '622: Visual hallucinations and fluctuating consciousness relate to pathology of the limbic thalamus in Lewy body dementias', Journal of Clinical Neuroscience, 14, pp. 1025 - 1025, http://dx.doi.org/10.1016/j.jocn.2007.02.053

Sutherland GT; Sue C; Mellick GD; Lee L; Rowe DB; Silburn PA; Halliday GM, 2007, '643: Promotor polymorphisms lowering parkin expression reduce the age of onset of Parkinson’s disease', Journal of Clinical Neuroscience, 14, pp. 1033 - 1033, http://dx.doi.org/10.1016/j.jocn.2007.02.074

Sutherland GT; Mellick GD; Sue C; Chan DK; Rowe DB; Silburn PA; Halliday GM, 2007, 'A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson`s disease', Neuroscience Letters, 414, pp. 170 - 173

Kipps C; Davies R; Mitchell J; Kril J; Halliday GM; Hodges JR, 2007, 'Clinical significance of lobar atrophy in frontotemporal dementia: Application of an MRI visual rating scale', Dementia and Geriatric Cognitive Disorders, 23, pp. 334 - 342

Dedov V; Griffiths F; Garner B; Halliday GM; Double KL, 2007, 'Lipid content determines aggregation of neuromelanin granules in vivo', Journal of Neural Transmission - Supplement, 72, pp. 35 - 38

Cairns NJ; Bigio E; Mackenzie IR; Neumann M; Lee VM; Hatanpaa K; White CL; Schneider JA; Grinberg LT; Halliday GM; Duyckaerts C; Lowe JL; Holm I; Tolnay M; Okamoto K; Yokoo H; Murayama S; Woulfe J; Munoz DG; Dickson D; Ince PG; Trojanowski JQ; Mann DM, 2007, 'Neuropathological diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration', ACTA Neuropathologica, 114, pp. 5 - 22

Song YC; Lundvig DM; Huang Y; Gai WP; Blumbergs PC; Hojrup P; Otzen D; Halliday GM; Jensen PH, 2007, 'p25alpha relocalizes in oligodedroglia from myelin to cytoplasmic inclusions in multiple system atrophy', American Journal of Pathology, 171, pp. 1291 - 1303

Taylor JM; Song YC; Huang Y; Farrer M; Delatycki MB; Halliday GM; Lockhart PJ, 2007, 'Parkin co-regulated gene (PACRG) is regulated by the ubiquitin-proteasomal system and is present in the pathological features of parkinsonian diseases', Neurobiology of Disease, 27, pp. 238 - 247

Huang Y; Halliday GM; Vandebona H; Mellick GD; Mastaglia F; Stevens J; Kwok JB; Garlepp M; Silburn PA; Horne MK; Kotschet K; Venn A; Rowe DB; Rubio J; Sue C, 2007, 'Prevalence and clinical features of common LRRK2 mutations in Australians with Parkinson`s disease', Movement Disorders, 27, pp. 982 - 989

Shepherd CE; Grace E; Mann DM; Halliday GM, 2007, 'Relationship between neuronal loss and 'inflammatory plaques' in early onset Alzheimer's disease', Neuropathology and Applied Neurobiology, 33, pp. 328 - 333

Behnke S; Double KL; Duma SR; Broe T; Guenther V; Becker GJ; Halliday GM, 2007, 'Substantia nigra echomorphology in the healthy very old: Correlation with motor slowing', Neuroimage, 34, pp. 1054 - 1059

Sutherland GR; Nowak G; Halliday GM; Kril J, 2007, 'Tau isoform expression in frontotemporal dementia without tau deposition', Journal of Clinical Neuroscience, 14, pp. 1182 - 1185

Litvan I; Halliday GM; Hallett M; Goetz CG; Rocca W; Duyckaerts C; Ben-Shlomo Y; Dickson D; Lang A; Chesselet M; Langston WJ; Di Monte DA; Gasser T; Hagg T; Hardy J; Jenner P; Melamed E; Myers RH; Parker Jr D; Price D, 2007, 'The etiopathogenesis of Parkinson Disease and suggestions for future research. Part 1', Journal of Neuropathology and Experimental Neurology, 66, pp. 251 - 257

Litvan I; Chesselet M; Gasser T; Di Monte DA; Parker Jr D; Hagg T; Hardy J; Jenner P; Myers RH; Price D; Hallett M; Langston WJ; Lang A; Halliday GM; Rocca W; Duyckaerts C; Dickson D; Ben-Shlomo Y; Goetz CG; Melamed E, 2007, 'The etiopathogenesis of parkinson disease and suggestions for future research. Part II', Journal of Neuropathology and Experimental Neurology, 66, pp. 329 - 336

Fedorow H; Halliday GM; Rickert CH; Gerlach M; Riederer P; Double KL, 2006, 'Evidence for specific phases in the development of human neuromelanin', Neurobiology of Aging, 27, pp. 506 - 512, http://dx.doi.org/10.1016/j.neurobiolaging.2005.02.015

Back to profile page